Skip to main content
logo
Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
29.40
-3.44 (-10.48%)
At close: Jun 5, 2026, 4:00 PM EDT
29.80
+0.40 (1.36%)
After-hours: Jun 5, 2026, 7:54 PM EDT

Beam Therapeutics Revenue

Beam Therapeutics had revenue of $31.74M in the quarter ending March 31, 2026, with 324.87% growth. This brings the company's revenue in the last twelve months to $164.01M, up 157.97% year-over-year. In the year 2025, Beam Therapeutics had annual revenue of $139.74M with 120.01% growth.

Revenue (ttm)
$164.01M
Revenue Growth
+157.97%
P/S Ratio
17.84
Revenue / Employee
$314,197
Employees
522
Market Cap
2.93B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025139.74M76.23M120.01%
Dec 31, 202463.52M-314.19M-83.18%
Dec 31, 2023377.71M316.79M520.01%
Dec 31, 202260.92M9.08M17.51%
Dec 31, 202151.84M51.82M215,916.67%
Dec 31, 202024.00K6.00K33.33%
Dec 31, 201918.00K--
Dec 31, 2018---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Telix Pharmaceuticals803.79M
Arcutis Biotherapeutics415.62M
Arcus Biosciences236.00M
Tango Therapeutics56.99M
Relay Therapeutics10.68M
Revenue Rankings

BEAM News

More News